STATE OF ALASKA, DEPARTMENT OF REVENUE Regeneron Pharmaceuticals, Inc. Transaction History

STATE OF ALASKA, DEPARTMENT OF REVENUE portfolio value:

$21.86M
portfolio value

STATE OF ALASKA, DEPARTMENT OF REVENUE quarter portfolio value change:

+16.53%
quarter

Regeneron Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -28.84% -12.86K shares -4.50M $688.87 31.73K
Q2 2022 share Increase +68.53% 18.13K shares 7.88M $591.13 44.60K
Q1 2022 share Increase +15.62% 3.57K shares 4.02M $698.42 26.46K
Q4 2021 share Increase +25.62% 4.66K shares 3.42M $642.51 22.89K
Q3 2021 share Increase +1.12% 202 shares 962K $605.18 18.22K
Q2 2021 share Decrease -35.49% -9.91K shares -3.15M $558.54 18.01K
Q1 2021 share Decrease -4.69% -1.37K shares -942K $473.14 27.93K
Q4 2020 share Decrease -4.43% -1.35K shares -3.00M $483.11 29.30K
Q3 2020 share Decrease -15.63% -5.68K shares -5.50M $559.78 30.66K
Q2 2020 share Increase +164.57% 22.60K shares 15.95M $623.65 36.34K
Q1 2020 share Increase +4.61% 605 shares 1.77M $488.29 13.73K
Q4 2019 share Decrease -7.66% -1.09K shares 985K $375.48 13.13K
Q3 2019 share Increase +11.30% 1.44K shares -53K $277.4 14.22K
Q2 2019 share Decrease -2.42% -317 shares -1.37M $313 12.77K
Q1 2019 share Decrease -1.84% -246 shares 394K $410.62 13.09K
Q4 2018 share Decrease -0.54% -73 shares -437K $373.5 13.34K
Q3 2018 share Decrease -2.37% -326 shares 680K $404.04 13.41K
Q2 2018 share Increase +23.90% 2.65K shares 921K $344.99 13.74K
Q1 2018 share Increase +19.12% 1.78K shares 319K $344.36 11.09K
Q4 2017 share Increase +638.89% 8.05K shares 2.93M $375.96 9.31K
Q3 2017 share Increase 0.00% 1.26K shares 563K $447.12 1.26K